RFK Jr urges Alzheimer’s screening but blunts key panel that could drive research

US Health Secretary Robert F Kennedy Jr. has publicly called for enhanced screening measures for Alzheimer's disease, aiming to improve early detection and intervention strategies. His advocacy highlights a growing concern over the impact of cognitive decline on public health.

Despite this push for better screening, a critical federal body, the US Preventive Services Task Force (USPSTF), has been unable to convene for more than a year. This panel plays a vital role in evaluating medical evidence and issuing recommendations that guide healthcare providers and researchers, particularly in developing practical methods for screening cognitive impairment.

Experts in the field have expressed reservations about the current evidence base for the specific type of cognitive screening that the health secretary appears to favor. The USPSTF had been scheduled to release recommendations on cognitive decline screening this year, alongside other public health topics, but its prolonged inactivity has stalled progress.

The task force's planned recommendation was part of a broader agenda that included evaluations for conditions ranging from autism to food allergy prevention. The delay in the USPSTF's meetings raises concerns about the pace of research and the implementation of evidence-based practices in addressing significant health challenges like Alzheimer's disease.